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a  b  s  t  r  a  c  t
Application  of  gas  chromatography–triple  quadrupole  mass  spectrometry  for  identification,  confir-
mation  and  quantification  of  6 phosphodiesterase-5  (PDE-5)  inhibitors  (sildenafil,  dimethylsildenafil,
homosildenafil,  thiosildenafil,  thiodimethylsildenafil  and  thiohomosildenafil)  in  dietary  supplements
was  investigated.  The  MS was  operated  in  multiple  reaction  monitoring  mode,  for  better  sensitivity  and
selectivity.  In  this  manner,  the  method  is adequate  to reduce  background  noise  with  less interference  from
co-eluting  compounds  in  the  samples.  Two  different  ionisation  techniques,  electron  ionisation  (EI)  and
chemical  ionisation  (CI),  were  studied  and  compared.  The  chromatographic  separation  was  performed
on a  short  10  m  non-polar  capillary  column  without  any  derivatisation  step.  This permitted  fast  analysis
for  all  analogues  with  retention  time  less  than  11  min,  for  both  techniques.  Use  of backflushing  can  aid
method  retention  time  reduction  and  improves  column  maintenance.  Evaluation  of  method  validation
included  limit  of detection  (LOD),  lower  limit  of  quantitation  (LLOQ),  linearity,  precision  and  recovery
were  performed  for  both  EI  and  CI  techniques.  The  LOD  obtained  varied  from  0.03  to 1.50  g/g  and  the
LLOQ  ranged  from  0.10  to  5.00  g/g.  Good  calibration  linearity  was  obtained  for  all  analogues  for  both
techniques,  with  correlation  coefficients  (r2) higher  than  0.99.  Mean  recoveries  of  all  analogues  using
CI  show  higher  values  (83.4–108.8%)  than that of  EI  (61.9–91.1%).  The  intra-  and  inter-assay  precisions
were  evaluated  for all  analogues  at spiked  concentration  of  10 g/g and  the  relative  standard  deviation
was  less  than  15%  for both  methods.  These  methods  were  then  successfully  applied  to  dietary  supple-
ment  samples  without  prior  derivatisation,  confirming  that  the  samples  were  adulterated  with  sildenafil
and/or  its analogues.
© 2016  Elsevier  B.V.  All  rights  reserved.. Introduction
Sildenafil citrate is a synthetic phosphodiesterase type 5 enzyme
nhibitor (PDE-5), used to treat male erectile dysfunction (ED)
nd pulmonary arterial hypertension (PAH). It is widely marketed
nder the name Viagra® (manufactured by Pfizer) [1]. The U.S Food
nd Drug Administration (FDA) has approved this drug, together
ith vardenafil (Levitra®, manufactured by Bayer) and tadalafilCialis®, developed and marketed by Lilly ICOS). However, sev-
ral sildenafil analogues are increasingly found as adulterants in
ood and nutrient supplements outside the official health system.
∗ Corresponding author.
E-mail address: Philip.marriott@monash.edu (P.J. Marriott).
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731-7085/© 2016 Elsevier B.V. All rights reserved.These analogues are structurally modified in the piperazine moi-
ety or carbonyl in pyrazolopyrimidine moiety substituted with a
thiocarbonyl group [2]. For instance, thioketone analogues may
be synthesised by heating sildenafil with phosphorus pentasulfide
(P2S5) and the C O bond exchanged to C S bond. Furthermore,
such analogues are not generally registered as drug substances
by the European Medicine Agency (EMA) and U.S Food and Drug
Administration (FDA), but may be present as adulterants [3]. They
can be considered as “designer drugs” and have no established
safety profile. It is important to monitor these drugs because
they can cause problems including adverse effects on cardiovas-
cular function such as arterial systemic blood pressure reduction,
headaches, facial flushing, dyspepsia, visual disturbances and back
pain [4].
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Table  1
Significant peaks in EI and CI full scan MS for sildenafil and its analogues by GC–QQQMS with the relative ion abundances (%). Most abundant peak for each compound is
shown  in bold.
Analyte Molecular ion, M+a Abundance peaks in full scan MS  in order of relative abundance (%)
EI CI
Sildenafil 474.2 99.1 (100), 56.1 (30), 404.3 (10), 474.7 (0.1) 475.3 (100), 313.2 (12.3)
Dimethylsildenafil 488.2 113.2 (100), 70.1 (20), 488.4 (0.1) 489.3 (100), 313.2 (18.1)
Homosildenafil 488.2 113.1 (100), 70.1 (47.5), 404.3 (10), 488.4 (0.3) 489.4 (100), 313.3 (14.9)
Thiosildenafil 490.2 99.1 (100), 56.1 (32.5), 420.2 (7.5), 490.3 (0.8) 491.3 (100), 223.1 (15.2), 299.2 (12.7)



















































Thiohomosildenafil 504.2 113.1 (100)
a Molecular ion for each compound according to isotopic distribution (m/z).
Recently, numerous websites have been launched, offering
arious formulations for sale that potentially contain PDE-5. Inter-
stingly, they often claim that the products (e.g., herbal products,
ietary supplements or food products) are safe by labeling them as
all natural”. Products may  be sold at cheaper price, as compared to
ther health products, which have been approved by the FDA and
ther national regulatory bodies. They are adulterated by minor
odification of the parent structure of approved PDE-5 inhibitors
5]. Development of a sensitive and accurate method to screen and
onfirm the illegal adulterants in dietary supplements, herbal and
ood products are of urgent priority.
Most studies reporting identification of sildenafil and its ana-
ogues have used liquid chromatography coupled with mass
pectrometry (LC–MS) [6,7], high performance liquid chromatog-
aphy (HPLC) [8,9], LC–tandem MS  (LC–MS/MS) [9–12] and
ltra-performance LC-time of flight MS  [13]. Recently, high
esolution benchtop quadrupole-Orbitrap (Q-Orbitrap) mass spec-
rometry was  applied for the detection of illegal adulterants in
erbal medicines and dietary supplements [14]. However, the
onventional HPLC method has a limitation because the method
annot supply characteristic mass spectral library data, which
an assist to discriminate between a wide range of analogues or
hemicals. Application of analytical gas chromatography (GC) is
argely restricted to low molecular mass, higher volatility and ther-
ally stable compounds [5]. Thermal stability and volatility may
e improved through derivatisation, but it is difficult to deriva-
ise sildenafil analogues with standard silylation reagents [15].
evertheless, GC may  be a preferred option because of simplic-
ty, affordability, low maintenance and well defined MS  library
atabases compared to LC–MS. GC with MS  (GC–MS) has been
pplied to analyse sildenafil, tadalafil and vardenafil in several
amples such as biological samples [16–20] food supplements
13,21], and herbal products [22] and pharmaceutical product [23].
owever, few studies report determination of either thio or non-
hio sildenafil analogues by GC–MS. Thus, further investigation is
equired because the safety of these analogues has not been clin-
cally tested, and there is a lack of MS  library data for sildenafil
dentification. Prior study identified several thioketone analogues
f sildenafil by using GC–MS, focusing on fast identification of the
nalogues with characteristic mass fragmentations, without fur-
her investigation [2].
To improve the identification power of GC–MS, GC–MS/MS with
 triple quadrupole instrument can be used to provide greater sen-
itivity and selectivity of identification because it allows the classic
ossibility to monitor only the analyte of interest through selec-
ion of appropriate ions. Operation in multiple reaction monitoring
MRM)  mode (also termed selected reaction monitoring; SRM)
s beneficial to accurate identification, confirmation and quan-
ification of some components in a sample [24]. Using the first
uadrupole for precursor ion selection, the second as collision cell,
nd the third quadrupole for product ion selection, high discrimi-
ation against background signals should be achievable [25].(32.5), 420.2 (5), 504.4 (1.2) 505.3 (100), 313.3 (7.5), 223.2 (5.2)
Further, chemical ionisation (CI) can support ionisation of labile
drugs, in contrast to electron ionisation (EI). The CI soft ionisa-
tion technique produces minimal fragmentation of molecular ions,
so the molecular species can be more readily identified [26]. The
CI mode is particularly useful in target analysis when the molec-
ular weight is known, such as in determination of volatile fatty
acids [27], amphetamines [28], amino acids [29] and others. Fur-
thermore, use of CI and MRM  mass spectra can be used as a
supplemental database simultaneously with an EI mass spectrum
database [30].
The aim of this study was to demonstrate rapid identification
and quantification for sildenafil and its analogues without use of
derivatisation, by using GC–QQQMS with both EI and CI techniques.
The method was then applied to analysis of PDE-5 in dietary sup-
plements. To date, little quantitative analysis has been applied to
sildenafil and its analogues using GC.
2. Experimental
2.1. Chemicals and reagents
Standards of six sildenafil and its analogues (sildenafil,
dimethylsildenafil, homosildenafil, thiosildenafil, thiodimethyl-
sildenafil, and thiohomosildenafil) were obtained from TLC
PharmaChem Inc. (Vaughan, Ontario, Canada). Their chemical
structures are shown in Supporting information Fig. S1. Ethyl
acetate was  purchased from Merck kGaA (Darmstadt, Germany)
while octacosane (C28) alkane used as internal standard (IS), was
obtained from Sigma–Aldrich (St. Louis, USA). Stock solutions of
each analyte were prepared as 100 g/mL stock solutions in ethyl
acetate and stored at −4 ◦C. Mixtures of lower concentration stan-
dard solutions were prepared via dilution of the stock solutions
in ethyl acetate and prepared fresh daily when analysis was  con-
ducted.
2.2. Instrumentation
Analyses were determined using a Bruker Scion 456 TQ
GC–MS/MS system (Bruker, Preston, Australia) operated by MS
Workstation version 8. Separations were carried out using a BPX5
capillary column (10 m × 0.25 mm I.D × 0.1 m film thickness (df);
SGE Analytical Science, Australia). Under fast GC–MS/MS, the initial
column temperature was  set at 150 ◦C (0 min), increased to 320 ◦C
at 20 ◦C/min and held for 5 min. An injection volume of 1 L was
employed in the splitless mode. Helium was  used as carrier gas at
a constant flow rate of 1.5 mL/min. Temperatures of the injector
and the transfer line were held at 280 ◦C and 300 ◦C, respectively.
The MS  was  operated in either full scan or MRM/SIM mode using
electron ionisation (EI) energy of 70 eV with ion source temper-
ature at 280 ◦C. The mass scan range for full scan mode was m/z
50–550 and the abundance ions obtained are listed in Table 1. The
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urity) as collision gas at 0.1 mTorr for collision-induced dissoci-
tion (CID); filament emission current of 80 A. The analysis was
erformed with a solvent delay of 4 min  to prevent filament dam-
ge. The quantification ion and qualification ion transitions, and
ptimised collision energy for each analyte are listed in Table 2.
he NIST MS  (Version 2.0) library was used to compare mass spec-
ra only for the sildenafil compound, since the other analogues were
ot available in the database.
A comparative study was performed using an Agilent 7890A
C system coupled to an Agilent 7000 GC–MS triple quadrupole
ass spectrometer (Agilent Technologies, Santa Clara, USA). All
arameters for GC operation were similar as for EI-MS above. The
gilent MS/MS  system was equipped with a chemical ionisation
PCI) source and was operated in positive ion mode with both full
can (mass range m/z 150–550) and multiple reaction monitoring
MRM). Methanol was used as the reagent gas and maintained at
0% flow (approximately 1 mL/min) for the positive CI mode. Nitro-
en (99.9999% purity) was used as the collision gas with a flow rate
t 1.5 mL/min, and helium (99.9999% purity) was mixed with the
ollision gas in the collision cell at a flow rate of 2.25 mL/min. The
ransfer line, source and quadrupole temperatures were 300, 300
nd 150 ◦C, respectively. Other MS  operating conditions remained
he same. Collision energy was adjusted as required for best sensi-
ivity for the selected transitions.
.3. Sample preparation
The dietary supplements were purchased online, and the sam-
les were presented in the form of capsules. The shells of capsules
ere removed, and approximately 0.2 g powder was accurately
eighed. The sample was transferred to a vial, and 5 mL  of ethyl
cetate was added. The sample was mixed thoroughly by vortex-
ng for 1 min, followed by 15 min  ultrasonic treatment and cooled
o room temperature. Then, the samples were filtered through a
.45 m membrane filter and diluted to an appropriate concentra-
ion for analysis.
.4. Method validation
The performance of the method was assessed by estimation of
everal parameters such as limit of detection (LOD), lower limit
f quantitation (LLOQ), linearity, precision and recovery. Method
alidation for assaying sildenafil and its analogues in dietary
upplements was conducted according to US Food and Drug Admin-
stration (USFDA) guidelines [31]. The LOD was determined as the
able 2
elected EI and CI MRM  transitions for each compound with the best collision energy (CE
Analyte EI MRM  transition 
Precursor iona Product ion 
Sildenafil 404 311.9 
474  99.2 
Dimethylsildenafil 488 311.9 
488  112.9 
Homosildenafil 488 112.9 
488  403.7 
Thiosildenafil 490 420.2 
490  98.2 
Thiodimethylsildenafil 504 112.8 
504  328 
Thiohomosildenafil 504 112.6 
504  421.3 
a Precursor ion chosen ± 0.5 Da.
b Collision energy (eV); argon gas.d Biomedical Analysis 121 (2016) 188–196
minimum concentration at a signal-to-noise ratio of at least 3
(S/N > 3) while LLOQ was the lowest concentration of the calibra-
tion curve, giving a signal-to-noise ratio of at least 10 (S/N > 10)
with acceptable accuracy and precision. The linearity of the method
was assessed by the coefficient of correlation (r2) of a 5-point cal-
ibration curve that was  constructed by plotting relative response
(analyte/IS, peak area) according to analyte concentration. Each cal-
ibration point was prepared in triplicate for each analogue. To assay
the accuracy of the method, mean recoveries were studied. The
recovery and precision experiments were performed by spiking
a known amount of mixed standard into a blank sample at con-
centration of 10 g/g. The experiment was  conducted by injecting
the sample into the system 6 times for intra-assay, and this proce-
dure was repeated with a fresh spiked sample daily, over 6 days,
for inter-assay validation. Then, the average percentage of recov-
ery and relative standard deviation (RSD) were calculated for each
analogue.
3. Results and discussion
3.1. Identification and confirmation of each analogue
Here, a fast approach was implemented with high initial col-
umn  temperature (150 ◦C) and relatively high temperature ramp
rate (20 ◦C/min) was applied. A non-polar short capillary column
(10 m) was chosen to reduce upper oven T and prolong column life
[22]. In addition, a thinner film phase column was used to minimise
retention of the high boiling point analogues; they still eluted at
T > 300 ◦C. In this study, acceptable separations were observed for
all analogues in both EI and CI methods with retention time less
than 11 min. In a method variation, backflushing by use of a Deans
switch can protect the column by removing low volatility com-
pounds that might only slowly travel through the column. As soon
as the analytes of interest are eluted, backflushing for a few column
volumes will clean the column, ready for the next injection.
Each standard was  injected directly into the GC using split-
less injection to provide MS  identification of each compound, and
establish their retention time in both techniques. However, most
compounds apparently were not included in the NIST libraries;
only sildenafil was observed in the NIST MS  library software. Thus,
identification of the analogues was  performed by interpreting each
fragmentation pattern obtained from both EI and CI techniques.
To support identification of each analogue, reference to previous
studies was made [2,15].
).
CI MRM  transition
CEb (eV) Precursor iona Product ion CEb (eV)
30 475.3 99.9 40
10 475.3 282.9 40
40 489.4 98.9 40
10 489.4 112.8 40
20 489.3 98.9 40
40 489.3 112.9 40
40 491.3 342.8 30
10 491.3 326.9 30
20 505.4 326.9 20
40 505.4 113 40
20 505.3 342.8 30
40 505.3 326.8 30
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Fig. 1. EI full scan mass spectra with interpreted fragmentation pattern for each
analogue; (a) sildenafil, (b) dimethylsildenafil, (c) homosildenafil, (d) thiosildenafil,
(e) thiodimethylsildenafil and (f) thiohomosildenafil.
Fig. 2. CI full scan mass spectra for each compound with relative ion abundances
(%); (a) sildenafil, (b) dimethylsildenafil, (c) homosildenafil, (d) thiosildenafil, (e)
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Fig. 1 shows full scan EI spectra with postulated fragmentation
athways produced by each analogue. For sildenafil, an abundant
/z  99 ion in the mass spectrum results from cleavage of the S N
ond between the piperazine ring and the sulfonyl group. Ion m/z
04 results from the cleavage of two C C bonds of the piperazine
oiety [32], as shown in Fig. 1. Dimethylsildenafil varies from
arent sildenafil by an additional methyl group attached to the
iperazine moiety. It alters the fragment ion mass by producing
 m/z 113 ion (2-methyl bonded) for dimethylsildenafil compared
o that of the analogous fragment ion m/z 99 for sildenafil. Although
oth dimethylsildenafil and homosildenafil have the same nominal
olar mass (488 g/mol), they can be differentiated by the fragment
on m/z 404, which only arises in the MS  result of homosildenafil.
rom their structures, they differ by the alkyl group(s) bonded to
iperazine moiety; an ethyl group for homosildenafil compared to
wo methyl groups for dimethylsildenafil. As reported previously
2], m/z 312 and 283 result from fragmentation of the pyrazolopy-
imidine moiety from sulfoxide and subsequent loss of the ethyl
roup on the ethoxy substituent of the phenyl ring, respectively.
his fragmentation not only occurred in sildenafil, but a similar
attern also can be observed in dimethylsildenafil and homosilde-
afil. Due to the presence of sulfur in thioketone analogues, the
ass fragmentation pattern theoretically generates m/z 328 and
99, corresponding to 16 mass units greater than non-thioketone
nalogues.
The difference between non-thioketone analogues and thioke-
one analogues is the substitution of oxygen by the sulfur atom
t the pyrazolopyrimidine moiety. The fragmentation pattern for
hiosildenafil was similar to that of sildenafil, but the only dif-
erence is addition of 16 mass units arising from the presence
f sulfur. Thiodimethylsildenafil and thiohomosildenafil share the
ame molar mass of 504 g/mol but again differ by the alkyl sub-
titution on the piperazine moiety. Both thio-analogues can be
ifferentiated by the presence of peak m/z  420, which only appear
n the mass spectra of thiohomosildenafil. This ion resulted from
he cleavage of two C C bonds of the piperazine moiety of thio-
omosildenafil. All the fragment ions and molecular ions for each
ompound are listed in Table 1.
Based on Fig. 1, the molecular ion obtained from the EI tech-
ique for each compound showed very low abundance compared
o the base peak. Thus, a CI source was applied to provide molecular
on information for each compound, with minimal fragmentation.
able 1 demonstrates that the most abundant ion is contributed by
he protonated molecular ions, [M + H]+. The presence of the pro-
onated molecular ion can assist identification of each analogue,
nd provides highly specific detection of analytes of interest when
ombined with retention information. As shown in Fig. 2, all mass
pectra are simple, with considerably less fragmentation than when
sing EI, with a dominant protonated molecular ion as base peak.
ther fragment ions appeared, but in very low relative abundance
<10%). For non-thioketone analogues, the m/z 313.2 fragment ion
as obtained as shown in the mass spectra of sildenafil, dimethyl-
ildenafil and homosildenafil. This ion results from cleavage of the
yrazolopyrimidine moiety from sulfoxide. Furthermore, CI mass
pectra can be used as supplementary library database information
ogether with EI mass spectra. As compared with the EI technique,
he identification of each analogue by CI provides high selectivity
nd high sensitivity due to lower interference from the matrix.
.2. GC–QQQMS optimisation
Analysis of sildenafil and it analogues by using MS/MS  provides
reater sensitivity and selectivity. Furthermore, the identification
f detected analytes is more reliable at low concentration, with
reater confidence for confirmation compared to conventional full
can GC–MS. Several parameters were evaluated such as precur-d Biomedical Analysis 121 (2016) 188–196
sor ion (Q1) and product ion (Q3) selection, and collision energy
(CE) to achieve the above. Time windows were set corresponding
to retention time of each analogue, with the selected ion masses.
Multiple windows allow more data points per peak because fewer
compounds are present in the window, and the number of transi-
tions will be fewer, therefore allowing faster cycle times. The MRM
method was  developed with both EI and CI techniques, based on
respective full scan mass spectra data. At first, the most abundant
ion in the mass spectrum was chosen as precursor ion. However, if
the result did not provide acceptable sensitivity or selectivity, a few
factors can be taken into account such as specificity of the transi-
tion, and relative abundances of selected ion masses. In this study,
the molecular ion for each analyte was  chosen as the precursor ion
since this provides better fragmentation. Also, most of the com-
pounds have a common base peak, i.e., either m/z  99.1 or 113. Then,
a product ion scan was  performed at various collision energies (10,
20, 30 and 40 eV) to select the highest abundance product ion. In
addition, the choice of product ions was usually made on the basis of
the two  most abundant fragments at the respective CE value, where
nearly complete dissociation of the chosen precursor ion occurred
(Supporting information Fig. S2–S7). However, in some cases, the
second most intense ion transition is too weak, so it is necessary to
use a different precursor ion, to generate a more intense product
ion for qualitative identification purposes. This arises for sildenafil
where two  precursor ions (m/z 404 and 474) were selected to attain
better subsequent fragmentation. Thus, several factors need to be
considered to select the best ion transition which is unique only to
certain compounds with freedom from interferences [33].
Two selected fragmentation reactions were chosen for method
implementation, such that the first SRM transition was  selected
for quantification, and the second SRM transition was chosen for
qualification to support confirmation of each compound. Therefore,
MRM  transitions of one or two  precursor ions and two  product ions
were assigned for each analyte. From Table 2, it can be seen that
thiodimethylsildenafil and thiohomosildenafil shared similar first
transitions (quantification) but can be differentiated by the second
transition (qualification). Having different retention times ensures
there is no overlap of the quantification ion. While thiosildenafil
and thiodimethylsildenafil have very close elution times, they have
quite different MRM,  and so can be readily differentiated. The
optimised MRM  transition conditions are listed in Table 2. Fig. 3
displays the EI MRM  chromatogram of each compound including
respective retention times at specific time windows. Each peak
was obtained from the first ion transition at appropriate collision
energies (Table 2).
For CI, since protonated molecular ions constituted the most
abundant peak in the mass spectra, thus they were obvious choices
as precursor ion for each compound. As in the EI MRM  method, the
precursor ion was studied with product ion scans attained at differ-
ent collision energies (10, 20, 30 and 40 eV). The product ion spectra
for each analogue are shown in Supporting information Fig. S8.
Then, the two most abundant product ions were selected with the
best collision energy. The optimised parameters for each compound
using CI are listed in Table 2. Most of the product ions obtained from
CI MS/MS  are similar to those in the EI MS/MS method. Although
dimethylsildenafil and homosildenafil generated the same transi-
tions, good separation can be obtained by assigning them to specific
time windows (see Fig. 4). Since the most common ionisation prod-
uct in CI is the [M + H]+ ion, lower LOD can be achieved by the
MS/MS  set up configuration. This method holds great potential
when analysing samples with trace levels of analytes, to provide
a high sensitivity and selectivity screening method. Man  et al.
reported the only study of GC–MS for thioketone analogue iden-
tification. However, GC–MS with an EI source suffers from lack of
spectrum information due to structural similarity and co-eluting
compounds, and no reproducibility was  discussed [2]. In this study,
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Fig. 3. EI MRM  chromatograms for all standard analogues obtained from GC–EI–QQQMS with retention times; (a) sildenafil, (b) dimethylsildenafil, (c) homosildenafil, (d)











LODs and LLOQs. Three replicate injections were conducted for eachig. 4. CI MRM chromatograms for all standard analogues obtained from GC–CI–Q
hiosildenafil, (e) thiodimethylsildenafil and (f) thiohomosildenafil using first ion tr
C–MS/MS proved to be a novel method compared to previous
C methods because it provides rapid analysis of sildenafil, non-
hioketone and thioketone analogues with mass fragmentation
nformation by using both EI and CI modes, in conjunction with the
eproducibility study. Whilst no derivatisation step was conducted
ere, most previous GC methods employed derivatisation to anal-
se the compounds, according to the low volatility of sildenafil as
eported by Saisho et al. [16] and Pyo et al. [15] with EI–MS. with retention times; (a) sildenafil, (b) dimethylsildenafil, (c) homosildenafil, (d)
ons according to Table 2.
3.3. Method validation
The methodology was  verified through assessment of linear-
ity, LOD, LLOQ, precision and recovery. Table 3 shows the linear
range of the calibration curve for each analyte in the concentration
range of interest to this analysis, along with correlation coefficient,analysis. For EI, the linearity of a five-point calibration was exam-
ined over the concentration range of 0.1–20 g/g while for CI the
concentration range was  2–20 g/g. As can be seen in Table 3, the
194 S.U. Mokhtar et al. / Journal of Pharmaceutical and Biomedical Analysis 121 (2016) 188–196
Table 3










LLOQ (g/g) LOD (g/g)
Sildenafil 0.1–10 0.9987 0.1 0.03 2–20 0.9929 2 0.6
Dimethylsildenafil 0.1–10 0.9974 0.1 0.03 2–20 0.9964 2 0.6
Homosildenafil 0.1–10 0.9974 0.1 0.03 2–20 0.9948 2 0.6
Thiosildenafil 1–20 0.9958 1 0.3 5–20 0.9971 5 1.5
Thiodimethylsildenafil 1–20 0.9963 1 0.3 5–20 0.9905 5 1.5
Thiohomosildenafil 1–20 0.9921 1 0.3 5–20 0.9911 5 1.5
Table 4
Intra-assay precision and recovery (n = 6) and 6 inter-assay precision data for each analogue in spiked samples at concentration of 10 g/g for GC–EI–MS/MS and GC–CI–MS/MS.
Compounds Recovery (%) Precision, RSD (%)
Intraday (n = 6) Interday (n = 6 days, 6
replicates/day)
EI CI EI CI EI CI
Sildenafil 76.9 83.4 12.5 2.1 14.7 1.5
Dimethylsildenafil 67.8 100.3 9.8 1.2 13.3 1.9
Homosildenafil 67.4 100.8 7.7 1.1 13.1 2.4
Thiosildenafil 91.1 101.9 5.1 4.2 6.8 3.3
Thiodimethylsildenafil 61.9 108.8 8.2 1.9 8.3 3.1
Thiohomosildenafil 76.6 103.9 9.2 2.5 9.1 2.9
Fig. 5. Chromatograms of positive sample B with (a) i Full scan mode and (a) ii MRM mode by GC–EI–QQQMS, in which sildenafil was  detected in the sample.
Table 5
Results for sildenafil and analogues detected in 5 samples (g/g), n = 6.
Sample Sildenafil Thiosildenafil Thiodimethylsildenafil
EI CI EI CI EI CI
A 0.8 ± 0.1 2.6 ± 0.1 ND ND ND ND
B  4.7 ± 1.0 4.5 ± 0.3 ND ND ND ND
C  7.3 ± 2.3 20.3 ± 2.9 ND ND ND ND
D  NDa ND 3.9 ± 0.4 6.5 ± 0.5 ND ND
E  ND ND ND ND 2.4 ± 0.1 3.2 ± 0.1
a Not detected.
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Fig. 6. Chromatograms of positive sample B with (a) i CI Full scan mode and (a
alibration curves vs IS response showed good response vs con-
entration linearity, with correlation coefficients (r2) > 0.99 for all
nalytes. The LLOQ values are from 0.1–5 g/g for both techniques
hile the LODs of all analogues were estimated to be in the range
.03–0.3 g/g and 0.6–1.5 g/g for EI and CI, respectively. Through
n examination of both techniques, EI–MS/MS was  demonstrated to
ave a lower detection limit, and produces a more sensitive method
han CI–MS/MS.
The precision and recovery of the methods were evaluated
t a concentration of 10 g/g for both EI and CI. Each sample
as injected six times for intra-assay precision evaluation and
epeated for six consecutive days (inter-assay). The recoveries
nd intra/interday precisions obtained by the two approaches are
ummarised in Table 4. Comparable precision and recovery was
bserved for both EI and CI methods. The percentage recovery of
ach analyte was calculated by comparing the peak area of the
ample with the spiked analyte, to the peak area of the reference
tandard. Results indicated mean recoveries for all analogues were
ithin the range of 61.9–91.1% for EI and 83.4–108.8% for CI. From
able 4, the mean recoveries of all compounds by using EI were
ower, compared with CI, indicating the closeness of the response
f the spiked sample to the response of the each standard analogue
or CI. Intraday and interday precision were calculated based on RSD
alues obtained for each spiked sample. Evidently CI had lower RSD
alues (<5%) for all analogues, ranging from 1.1–4.2% to 1.5–3.3% for
ntra-assay and inter-assay validation, respectively compared to EI
<13%). Apparently, adequate method precision and robustness of
he method is attained.
.4. Analysis of dietary supplement samples
The proposed method was applied to check the presence of
ildenafil and its analogues in five dietary supplements, which were
urchased online in Singapore. For positive samples with concen-
rations higher than the working range, the sample solution was
iluted to produce responses within the working range. The iden-
ification of target compounds was based on the MRM  mode with
pecific time windows. The sample was considered negative if no
ignal was detected, or the signal was below the LOD levels withinMRM  mode by GC–CI–QQQMS, in which sildenafil was detected in the sample.
respective time windows. Results indicated that all samples were
confirmed to be positive samples, adulterated with sildenafil and
its analogues by both EI and CI techniques (see Figs. 5 and 6).
The amount of each analogue detected was calculated from the
calibration curve. Based on Table 5, it is noted that the sildenafil
was detected in sample A–C using both ionisation mode at spe-
cific concentrations. Sample D and E were illegally adulterated
with a thioketone analogue; thiosildenafil and thiodimethylsilde-
nafil, respectively. Agreement between EI and CI was reasonable
for the amount of sildenafil detected in Sample B. However, other
samples demonstrated higher concentrations of target compounds
were obtained by using CI than by EI (see Table 5), possibly due to
higher mean recoveries for all analogues in CI as discussed in Sec-
tion 3.3. The identification of the sildenafil analogues in adulterated
dietary supplements is crucial since many cases have been reported
recently on adulteration of food supplements, even though the FDA
has banned the use of class I drugs in dietary supplements. Results
proved that the proposed method was  adequate for simultaneous
identification, confirmation and quantitation of sildenafil and its
analogues in dietary supplements.
4. Conclusion
This paper reports the development of a GC–QQQMS method
for identification sildenafil and various analogues in dietary sup-
plements with two different ionisation techniques. By using the
triple quadrupole method with MRM  mode, the determination of
each analogue was shown to provide adequate sensitivity, selectiv-
ity and acceptable separation without a derivatisation step. It also
highlighted that this method provides rapid analysis because all
the target compounds were eluted within 11 min, for both EI and CI
techniques. Experiments were carried out to achieve the best con-
dition of MRM  transition for each analogue. Validation parameters
such as linearity, LLOQ, LOD, recovery and precision of this method
were acceptable. EI–MS/MS method demonstrated more sensi-
tive compared to CI–MS/MS. Nevertheless, the CI method plays an
important role for the identification of each analogue by providing
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